Understanding the molecular pathways that determine response to anti-angiogenic therapy

Funding Activity

Website
http://purl.org/au-research/grants/nhmrc/1045518

Funding Status
Closed

Does something not look right? The information on this page has been harvested from data sources that may not be up to date. We continue to work with information providers to improve coverage and quality. To report an issue, use the .

Funded Activity Summary

Anti-angiogenesis is an important new approach to treat conditions such as cancer and eye disease. Our study is designed to understand the molecular pathways that lead to patients either being or developing resistance to these treatments. Using advanced cell and molecular biology techniques we will identify ways in which the blood vessels evade these therapies. Once identified these molecules will provide additional targets for developing therapeutics and diagnostics.

Funded Activity Details

Start Date: 01-01-2013

End Date: 01-01-2013

Funding Scheme: NHMRC Project Grants

Funding Amount: $209,539.00

Funder: National Health and Medical Research Council

Research Topics

ANZSRC Field of Research (FoR)

Cancer Therapy (excl. Chemotherapy and Radiation Therapy)

ANZSRC Socio-Economic Objective (SEO)

There are no SEO codes available for this funding activity

Other Keywords

angiogenesis | cancer biology | cancer therapy | cancer treatment | endothelial cells

Related Links